Post-approval studies (Phase 4)Looking for participantsNCT07133659
What this trial is testing
Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study
Who this might be right for
ITP - Immune Thrombocytopenia
Al-Mustansiriyah University 25